BSEInsider Trading / SAST2d ago · 23 Sept 2026, 05:23 pm
Closure of Trading Window for 2nd Quarter and Half Year Ended on 30th, September, 2026
Gujarat Inject Kerala Ltd · 524238
✦ AI SummaryResults
Gujarat Inject Kerala Ltd has announced the closure of its trading window for the 2nd quarter and half year ended on 30th September, 2026, due to the upcoming declaration of unaudited financial results. The trading window will remain closed from 1st October, 2026, until 48 hours after the results are declared.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gujarat Inject Kerala Ltd - 524238 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
532cb2b3-7d39-4685-be91-81dc621bc7c5.pdf
View document text
GUJARAT INJECT (KERALA) LIMITED
CIN: L35105GJ1991PLC151872
Regd Office: SHOP NO 15 K-TOWER HAVELI RESIDENT CUM PLAZA, AIR FORCE STATION, Makarpura,
Vadodara, Vadodara, Gujarat, India, 390014
Administrative Office: A-416, Sun West Bank, Ashram Road P.O, Ahmedabad, City Ahmedabad, Gujarat,
India, 380009 Phones: 09898593314, 09712193314
E-Mail: murlisnair9032@gmail.com, admin@gikl.com Website: www.gujaratinject.com
23rd September, 2026
The Manager,
BSE Limited,
Department of Corporate Services,
Phiroze Jeejeebhoy Towers,
Dalal Street, Mumbai – 400 001
SCRIPT CODE: 524238
Dear Sir,
SUBJECT: INTIMATION OF CLOSURE OF TRADING WINDOW
In terms of the applicable provisions of Securities and Exchange Board of India (Prohibition
of Insider Trading) Regulations, 2015 as amended and trading restrictions placed by the
Company's Code of Practices, Procedure and Conduct to Regulate, Monitor and Report Trading
by Insiders (‘the Code’), we hereby inform that the Trading Window for purchasing / selling
or dealing in the Equity Shares of the Company, will remain closed for all Insiders, Directors,
Promoters and Designated Persons of the Company from Thursday, 01st October, 2026 till the
expiry of 48 hours after the declaration of the Unaudited Financial Results for the 2nd Quarter
& half year ended on 30th September, 2026 to the Stock Exchange.
The date of Board Meeting for approval of the Financial Results for the Quarter and half year
ended on 30th September, 2026, will be announced in due course.
Kindly take this information on your record.
Thanking you.
Yours Faithfully,
FOR GUJARAT INJECT KERALA LTD
MURLI SHIVSHANKARAN NAIR
ADDITIONAL DIRECTOR (MANAGING DIRECTOR)
DIR: 02243039